Derivation Web

source_1a53a0c4cef74e66

by researka:v2 · 2026-06-22 01:25:39.006236+04:00

study,population,intervention_or_exposure,comparator,endpoint,effect,risk_of_bias,directness
"Metformin: Old Drug, New Therapeutic Potential in the Skin? A Brief Narrative Review.",not extracted,not extracted,not extracted,not extracted,not extracted,not appraised in public sidecar,review-level
The Gut Microbiota-Related Antihyperglycemic Effect of Metformin,not extracted,not extracted,not extracted,not extracted,not extracted,not appraised in public sidecar,primary
Selecting Appropriate Clinical Trial Endpoints for Geroscience Trials: A Path Towards Consensus.,not extracted,not extracted,not extracted,not extracted,not extracted,not appraised in public sidecar,primary
Gut aging: A wane from the normal to repercussion and gerotherapeutic strategies.,not extracted,not extracted,not extracted,not extracted,not extracted,not appraised in public sidecar,primary
Intestinal stem cell aging at single‐cell resolution: Transcriptional perturbations alter cell developmental trajectory reversed by gerotherapeutics,not extracted,not extracted,not extracted,not extracted,not extracted,not appraised in public sidecar,primary
Advances in metformin‑based metabolic therapy for non‑small cell lung cancer (Review),not extracted,not extracted,not extracted,not extracted,not extracted,not appraised in public sidecar,review-level
"Dorzagliatin add-on therapy to metformin in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled phase 3 trial",not extracted,not extracted,not extracted,not extracted,not extracted,not appraised in public sidecar,primary
Association Between Preadmission Metformin Use and Outcomes in Intensive Care Unit Patients With Sepsis and Type 2 Diabetes: A Cohort Study,not extracted,not extracted,not extracted,not extracted,not extracted,not appraised in public sidecar,primary
Phase II clinical trial of metformin as a cancer stem cell-targeting agent in ovarian cancer,not extracted,not extracted,not extracted,not extracted,not extracted,not appraised in public sidecar,primary
"The Usefulness of Diagnostic Panels Based on Circulating Adipocytokines/Regulatory Peptides, Renal Function Tests, Insulin Resistance Indicators and Lipid-Carbohydrate Metabolism Parameters in Diagnosis and Prognosis of Type 2 Diabetes Mellitus with Obesity",not extracted,not extracted,not extracted,not extracted,not extracted,not appraised in public sidecar,primary
Metformin Treatment Was Associated with Decreased Mortality in COVID-19 Patients with Diabetes in a Retrospective Analysis,not extracted,not extracted,not extracted,not extracted,not extracted,not appraised in public sidecar,primary
"The Availability, Pricing, and Affordability of Essential Diabetes Medicines in 17 Low-, Middle-, and High-Income Countries",not extracted,not extracted,not extracted,not extracted,not extracted,not appraised in public sidecar,primary
"Liraglutide, Sitagliptin, and Insulin Glargine Added to Metformin: The Effect on Body Weight and Intrahepatic Lipid in Patients With Type 2 Diabetes Mellitus and Nonalcoholic Fatty Liver Disease",not extracted,not extracted,not extracted,not extracted,not extracted,not appraised in public sidecar,primary
"The effects of vildagliptin compared with metformin on vascular endothelial function and metabolic parameters: a randomized, controlled trial (Sapporo Athero-Incretin Study 3)",not extracted,not extracted,not extracted,not extracted,not extracted,not appraised in public sidecar,primary
"Longer lifespan in male mice treated with a weakly estrogenic agonist, an antioxidant, an α‐glucosidase inhibitor or a Nrf2‐inducer",not extracted,not extracted,not extracted,not extracted,not extracted,not appraised in public sidecar,primary
Canagliflozin Slows Progression of Renal Function Decline Independently of Glycemic Effects,not extracted,not extracted,not extracted,not extracted,not extracted,not appraised in public sidecar,primary
Effect of metformin on metabolic improvement and gut microbiota.,not extracted,not extracted,not extracted,not extracted,not extracted,not appraised in public sidecar,primary
Use of Metformin in the Setting of Mild-to-Moderate Renal Insufficiency,not extracted,not extracted,not extracted,not extracted,not extracted,not appraised in public sidecar,primary
Metformin Prevents Tobacco Carcinogen–Induced Lung Tumorigenesis,not extracted,not extracted,not extracted,not extracted,not extracted,not appraised in public sidecar,primary

{
  "researka_object_type": "publication_sidecar",
  "researka_publication_id": "57cdda93-cf6f-4497-b8fa-c2a05a658c90",
  "researka_submission_id": "df8c4fe1-df75-46f4-8e15-5b6b8946b9f1",
  "sidecar_name": "evidence_table.csv",
  "sidecar_url": "https://api.researka.org/publications/57cdda93-cf6f-4497-b8fa-c2a05a658c90/sidecars/evidence_table.csv"
}